Antares Pharma, Inc.
NASDAQ: ATRS
$5.59
+$0.00 (+0.0%)
Closing Price on September 7, 2022
ATRS Stock Chart and Intraday Price
ATRS Stock Data
| Asset Type | ETF |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
ATRS Articles
The top analyst upgrades, downgrades and initiations seen for Monday included Allscripts Healthcare Solutions, AmeriGas Partners, CVS Health, IMAX, Kraft Heinz, Marathon Oil, Microsoft and Pfizer.
Published:
Last Updated:
AMAG Pharmaceuticals saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval.
Published:
Last Updated:
24/7 Wall St. has collected a few more catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
Published:
Last Updated:
Friday’s top analyst upgrades, downgrades and initiations include Costco, Domino's Pizza, Fortinet, Verizon Communications and Yum Brands.
Published:
Last Updated:
The Jefferies top U.S. growth picks for this week run the gamut, and all are suitable for more aggressive accounts.
Published:
Thursday's top analyst upgrades, downgrades and initiations include Antares Pharma, Michael Kors, Palo Alto Networks, Ralph Lauren, Chipotle Mexican Grill and Ericsson.
Published:
via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is that some...
Published:
ThinkstockEven the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend their coverage on stocks until they can replace the talent. Oppenheimer...
Published:
Last Updated: